3.1 LAE inhibits ER- breast cancer cells migration independent of nuciferine
To investigate LAE effects on cell migration, SK-BR-3, MDA-MB-231 and HCC1806 ER- breast cancer cell lines were used in the study. Previous studies have shown that cell proliferation interferes with cell migration. To rule out the effect of cell growth, the proliferation of breast cancer cells was examined by CCK8 assay with LAE supplement. The viability of SK-BR-3, MDA-MB-231 and HCC1806 cells were similar between with low dose (50 and 100µg/ml) of LAE supplement and without LAE (Fig. 1a). All of SK-BR-3, MDA-MB-231 and HCC1806 cells exhibited unchanged cell morphology with 100 µg/ml or less LAE supplement (Fig. 1b). However, cell number was significantly reduced with high doss (250µg/ml) of LAE supplement for 48 hours (Fig. 1a). These results indicated that low dose LAE did not alter breast cancer cell proliferation.
Next, we examined the LAE role in cell migration by wound healing assays with 50 and 250µg/ml LAE supplement for 36 hours. Previous studies found that FBS promote cell proliferation to alter cell migration. To rule out the effect of FBS, all experiments were performed in an FBS-free medium. Cell wound healing distance analysis showed that LAE supplement significantly reduced the wound healing distance in three subtypes cells, suggesting cell migration was suppressed (Fig. 1c). Interestingly, 50 or 250µg/ml LAE supplement showed similarly inhibitory effect on SK-BR-3 cells migration, while LAE supplement inhibited cell migration of MDA-MB-231 and HCC1806 cells in a dose dependent manner.
Nuciferine, a bioactive component of lotus, inhibits the growth of cancer cells and breast cancer-associated bone loss [22-23]. To verify if nuciferine is involved in the inhibition of cell migration by LAE, SK-BR-3, MDA-MB-231 and HCC1806 cells were treated with nuciferine supplement. Cell viability (Supplementary Fig. 3a) and migration (Supplementary Fig. 3b) were similar in the presence or absence of high dose of nuciferine, indicating that nuciferine was not associated with LAE-inhibited cell migration. Together, these results indicated that LAE supplement suppresses ER- breast cancer cells migration.
3.2 LAE-inhibited cell migration is independent of autophagy and Wnt signals
Autophagic process is recognized to suppress cancer metastasis through decreasing EMT . To determine if LAE-suppressed cell migration was regulated by autophagy and EMT-related Wnt/β-catenin signaling pathway directly, we examined β-catenin, snail, p62 and LC3 proteins levels by immunoblotting. Elevated LC3 protein level was observed in cells with high dose (100, 250µg/ml) of LAE supplement. However, p62 protein level was similar in cells with low and high dose of LAE supplement (Supplementary Fig. 1a). To verify the controversial results, we used autophagy/lysosome inhibitor chloroquine (CQ) to inhibit autophagy flux. Inhibition of autophagy flux did not alter cell migration, revealed by wound healing distance (Supplementary Fig. 1b). Unchanged β-catenin and snail protein levels were observed in three subtypes of breast cancer cells with low or high dose of LAE supplement (Supplementary Fig. 1c). To further determine the role of Wnt signaling pathway on the effect of LAE-inhibited cell migration, LiCl was used to activate the Wnt signal. Wound healing assays revealed that the activation of Wnt signal did not reverse the cell migration (Supplementary Fig. 1d), suggesting LAE-suppressed cell migration was independent of Wnt signaling pathway. Thus, LAE-suppressed cell migration is independent of autophagy and Wnt signaling pathways.
3.3 TGF-β1 is associated with LAE-suppressed cell migration
Considerable literatures showed that TGF-β1 is recognized as a major regulator of EMT to regulate tumor metastasis [25-27]. Then we tested the protein level of TGF-β1 after treating with LAE. The results showed that TGF-β1 was obviously reduced in SK-BR-3 and HCC1806 cells at both low (even 10µg/ml) and high concentrations of LAE (Fig. 2a). To further determine whether TGF-β1 signal was required for LAE-inhibited cell migration, 10ng/ml TGF-β1 with 100µg/ml LAE was used to treat SK-BR-3, MDA-MB-231 and HCC1806 cells. LAE-inhibited cell migration was significantly restored by the addition of TGF-β1 growth factor, as revealed by wound healing assays (Fig. 2b). Consistent with literatures, TGF-β1 growth factor changed cells morphology from epithelial to mesenchymal transition (EMT), which was suppressed by LAE supplement (Fig. 2c). Thus, these observations demonstrated that TGF-β1 signal is involved in LAE-inhibited cell migration likely via inhibition of EMT.
3.4 SMAD3 and Erk1/2 phosphorylation are inhibited
To figure out the signaling pathway involved in LAE-inhibited cell migration, we examined the canonical TGF-β1/SMAD3 signaling pathway and the non-canonical TGF-β1/PTEN/AKT and MAPKs signaling pathways [28-29]. Immunoblotting analysis showed that AKT phosphorylation and PTEN levels were unchanged in three subtypes of breast cancer cells with LAE supplement (Fig. 3a). Similar p38 and JNK phosphorylation levels were observed in cells with and without LAE supplement (Fig. 3a). However, the phosphorylated Erk1/2 level was significantly reduced in SK-BR-3 and HCC1806 cells even at a low LAE supplement (10µg/ml), and mildly reduced in MDA-MB-231 cells (Fig. 3b). Interestingly, with LAE supplement, the phosphorylated-SMAD3 level was significantly reduced in SK-BR-3 and MDA-MB-231 cells, but not in HCC1806 cells (Fig. 3c). Moreover, TGF-β1 supplement significantly restored Erk1/2 and SMAD3 phosphorylation levels individually or simultaneously which is inhibited by LAE supplement in three subtypes of breast cancer cells (Fig. 3d).
Mutant p53 mediates the TGF-β1 signaling pathway via Erk1/2 as well as SMAD3 signals, and the p53 in all of the three subtypes of breast cancer cells are mutant [30-33]. We next examined the mutant p53 protein level in three subtypes of breast cancer cells with LAE supplement. Although p53 protein level was similar in SK-BR-3 and HCC1806 cells with and without LAE supplement, immunoblotting results showed that p53 protein level was significantly decreased in MDA-MB-231 cells with LAE supplement in a dose dependent manner (Fig. 3e). Together, these results demonstrated that LAE inhibits the cell migration of ER- breast cancer cells likely via suppressing the phosphorylation of TGF-β1/Erk1/2 as well as TGF-β1/SMAD3 signals.
3.5 LAE downregulate hydrogen peroxide levle
Reactive oxygen species (ROS), especially hydrogen peroxide (H2O2), are associated with tumor metastasis [34-36]. TGF-β-related signals promote hydrogen peroxide production in several types of cells [37-39]. H2O2 enhances TGF-β-mediated EMT via SMAD and MEK/Erk signaling pathways . To determine if intracellular H2O2 participate in the TGF-β1-related cell migration inhibition, we first measured H2O2 level in cells with LAE supplement for 48 hours. With LAE supplement, intracellular H2O2 level was significantly downregulated in MDA-MB-231 and HCC1806 cells, but not in SK-BR-3 cells (Fig. 4a). Consistently, H2O2 scavenger catalase protein level was significantly increased even at a low concentration of LAE supplement (10µg/ml) (Fig. 4b). However, SOD1, NOX2 and NOX4 protein levels, responsible for the production of large amounts of ROS, were similar in cells with or without LAE supplement. Thus, LAE supplement reduced H2O2 production in MDA-MB-231 and HCC1806 cells, likely via enhancing the catalase protein level.
To determine if downregulated H2O2 level caused LAE-induced inhibition of breast cancer cell migration, we added 25nM H2O2 with 100µg/ml LAE supplement to treat SK-BR-3, MDA-MB-231 and HCC1806 cells. Wound healing distance results showed that the addition of H2O2 significantly restored LAE-inhibited cell migration in MDA-MB-231 and HCC1806 cells (Fig. 4c). However, SK-BR-3 cells displayed similar cell migration with or without H2O2 supplement, suggesting other signals were involved in LAE-inhibited cell migration. Interestingly, elevated intracellular H2O2 level was observed in MDA-MB-231 and HCC1806 cells with 10ng/ml TGF-β1 and 100µg/ml LAE compared to cells with single LAE supplement, but not in SK-BR-3 cells (Fig. 4d). These findings indicated that LAE inhibits TGF-β1-mediated cell migration via downregulating hydrogen peroxide in MDA-MB-231 and HCC1806 cells.
3.6 LAE inhibits tumor metastasis
To investigate the inhibitory effects of LAE on metastasis in vivo, we used subcutaneous xenograft nude mice models to examine tumor metastasis. The schedule of experiments was showed in Figure. 5a. To exclude the toxicity of LAE in vivo, xenograft nude female mice were fed with 0.5% LAE for 56 days and body weight of mice was monitored. Body weight in mice with and without LAE supplement was similar (Fig. 5b), indicating that LAE supplement did not cause systemic toxicity. Consistent with figure 1, LAE supplement did not alter the growth of in-situ tumor compared to controls (Fig. 5c). However, the number and weight of new metastatic tumors derived from the primary tumor were significantly decreased in mice with LAE supplement compared to controls (Fig. 5d). Immunoblotting results showed that LAE did not inhibit the phosphorylation of Erk1/2 and SMAD3 in liver. However, LAE supplement significantly downregulated the phosphorylation of Erk1/2 but not SMAD3 in lung (Fig. 5e). These data indicated that the effect of LAE on SMAD3 and Erk1/2 is dependent on tissue environment or extracellular signal stimulation.
Next, we used intravenous injection nude mice models to investigate the anti-metastatic role of LAE. The experiments schedule was showed in Fig. 6a. Strikingly, LAE supplement significantly suppressed mice body weight loss induced by tumor (Fig. 6b), which indicated that LAE may improve the weight loss in mice with advanced breast cancer. And the number and weight of new formed metastatic tumors were significantly decreased in mice with LAE supplement (Fig. 6c). Interestingly, we found less lung congestion in mice with LAE supplement than that of control animals (Fig. 6d). The number and size of metastatic tumor nodules in lung and liver was decreased significantly. H&E staining revealed inflammatory infiltration and vascular invasion in lung of mice, while LAE supplement improved inflammatory infiltration and vascular invasion in lung of mice (Fig. 6e). In liver, LAE supplement significantly decreased the number of large metastatic tumors. Mice with LAE supplement showed significantly downregulated phosphorylation of SMAD3 in lung and liver, but not the phosphorylation of Erk1/2 (Fig. 6f). Taken together, these data suggested that LAE inhibits tumor metastasis, at least in part, via suppressing the phosphorylation of SMAD3 and Erk1/2.
3.7 Extracellular matrix signal are associated with LAE-suppressed cell migration
To further explore the molecular mechanism of LAE inhibiting cell migration, we performed RNA-sequence to analysis gene expression profiles in SK-BR-3, HCC1806 and MDA-MB-231 cells after LAE treatment. All the differentially expressed genes were analyzed by (Gene Ontology) GO method in DAVID with the standard of P<0.001 and FDR<1. Results showed that extracellular matrix (ECM) organization, oxidation-reduction process, negative regulation of cell migration and cell adhesion were significantly enriched by LAE supplement in MDA-MB-231 cells (Supplementary Fig. 2a), and oxidation-reduction process, extracellular matrix organization, cell-cell adhesion and cell migration were significantly enhanced by LAE supplement in SK-BR-3 cells (Supplementary Fig. 2b), while extracellular region part and extracellular matrix part were significantly changed by LAE supplement in HCC1806 cells (Supplementary Fig. 2c). Furthermore, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis found that pathways involved in ECM-receptor interaction and focal adhesion as well as their related genes were significantly enriched (Supplementary Fig. 2d-f) in SK-BR-3, HCC1806 and MDA-MB-231 cells. Notably, the ECM components and cell adhesion could be induced by the TGF-β1 and FAK signaling pathways [41-44]. Taken together, our results demonstrated that LAE-suppressed cell migration are associated with multiple signaling pathways in different cell lines, likely via extracellular matrix signal.